by John A. Jenkins | Sep 11, 2024 | FDA, FOIA, FTC, SEC
FOIAengine Explores the Widespread Use of “Neither Confirm Nor Deny” By John A. Jenkins We’re taking a look this week at a frequently used Freedom of Information Act exemption that isn’t mentioned anywhere in the statutory language. It’s known as “Glomar” among the...
by Randy E. Miller | Aug 21, 2024 | Antitrust, Cryptocurrency, FOIA, FTC, News Media
FOIAengine Analysis Reveals Targets and Topics News media outlets continued to be the leading submitters of Freedom of Information Act requests to the Federal Trade Commission during the first half of 2024, with many of the requests focused on the agency’s...
by John A. Jenkins | Jul 30, 2024 | Antitrust, FOIA, FTC, Law Firms, Pharmaceuticals
FOIA Requests Target Scott Sheffield, King of the Frackers, Amid Reports of a Criminal Referral This week, we’re looking into how antitrust enforcers used their approval of an oil-industry megadeal to send a message about white-collar criminality. It’s a cautionary...
by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals
FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
by John A. Jenkins | Feb 7, 2024 | FOIA, FTC, Litigation
FOIAengine: Who’s Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall...
by John A. Jenkins | Jan 10, 2024 | Antitrust, FOIA, FTC, Law Firms, Litigation
Requests in FOIAengine Show Groups Watching the FTC When the Federal Trade Commission joined the Justice Department last month in announcing new merger guidelines, two years in the making, the revised rules of the road were a warning to acquisitive corporations: ...
